Kang HS - Search Results

1

Methylation patterns of genes coding for drug-metabolizing enzymes in tamoxifen-resistant breast cancer tissues.

Kim SJ, Kang HS, Jung SY, Min SY, Lee S, Kim SW, Kwon Y, Lee KS, Shin KH, Ro J. Kim SJ, et al. Among authors: kang hs. J Mol Med (Berl). 2010 Nov;88(11):1123-31. doi: 10.1007/s00109-010-0652-z. Epub 2010 Jul 14. J Mol Med (Berl). 2010. PMID: 20628863

2

High level expression of the bioactive human interleukin-10 in milk of transgenic mice.

Sohn BH, Chang HG, Kang HS, Yoon H, Bae YS, Lee KK, Kim SJ. Sohn BH, et al. Among authors: kang hs. J Biotechnol. 2003 Jun 12;103(1):11-9. doi: 10.1016/s0168-1656(03)00072-5. J Biotechnol. 2003. PMID: 12770500

3

CpG methylation of the ERalpha and ERbeta genes in breast cancer.

Kim SJ, Kim TW, Lee SY, Park SJ, Kim HS, Chung KW, Lee ES, Kang HS. Kim SJ, et al. Among authors: kang hs. Int J Mol Med. 2004 Aug;14(2):289-93. Int J Mol Med. 2004. PMID: 15254780

4

Tamoxifen-resistant breast cancers show less frequent methylation of the estrogen receptor beta but not the estrogen receptor alpha gene.

Chang HG, Kim SJ, Chung KW, Noh DY, Kwon Y, Lee ES, Kang HS. Chang HG, et al. Among authors: kang hs. J Mol Med (Berl). 2005 Feb;83(2):132-9. doi: 10.1007/s00109-004-0596-2. Epub 2004 Nov 5. J Mol Med (Berl). 2005. PMID: 15536519

5

Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy.

Kang SH, Kim SK, Kwon Y, Kang HS, Kang JH, Ro J, Lee ES. Kang SH, et al. Among authors: kang jh, kang hs. World J Surg. 2004 Oct;28(10):1019-24. doi: 10.1007/s00268-004-7367-7. Epub 2004 Sep 29. World J Surg. 2004. PMID: 15573258 Clinical Trial.

6

Epigenetic silencing of the sulfotransferase 1A1 gene by hypermethylation in breast tissue.

Kwon MS, Kim SJ, Lee SY, Jeong JH, Lee ES, Kang HS. Kwon MS, et al. Among authors: kang hs. Oncol Rep. 2006 Jan;15(1):27-32. Oncol Rep. 2006. PMID: 16328031

7

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.

Lee S, Kim EY, Kang SH, Kim SW, Kim SK, Kang KW, Kwon Y, Shin KH, Kang HS, Ro J, Lee ES. Lee S, et al. Among authors: kang hs, kang kw, kang sh. Breast Cancer Res Treat. 2007 May;102(3):283-8. doi: 10.1007/s10549-006-9330-9. Epub 2006 Oct 25. Breast Cancer Res Treat. 2007. PMID: 17063280 Clinical Trial.

8

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer.

Lee KS, Ro J, Nam BH, Lee ES, Kwon Y, Kwon HS, Chung KW, Kang HS, Kim EA, Kim SW, Shin KH, Kim SK. Lee KS, et al. Among authors: kang hs. Breast Cancer Res Treat. 2008 Jun;109(3):481-9. doi: 10.1007/s10549-007-9672-y. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653851 Clinical Trial.

9

Extent of routine central lymph node dissection with small papillary thyroid carcinoma.

Lee YS, Kim SW, Kim SW, Kim SK, Kang HS, Lee ES, Chung KW. Lee YS, et al. Among authors: kang hs. World J Surg. 2007 Oct;31(10):1954-9. doi: 10.1007/s00268-007-9171-7. World J Surg. 2007. PMID: 17687598

10

Promoter hypomethylation of the N-acetyltransferase 1 gene in breast cancer.

Kim SJ, Kang HS, Chang HL, Jung YC, Sim HB, Lee KS, Ro J, Lee ES. Kim SJ, et al. Among authors: kang hs. Oncol Rep. 2008 Mar;19(3):663-8. Oncol Rep. 2008. PMID: 18288399

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,936 results

Search Page

Filters